Daxor/$DXR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Daxor
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.
Ticker
$DXR
Sector
Primary listing
Employees
45
Headquarters
Website
Daxor Metrics
BasicAdvanced
$62m
5.85
$1.81
0.04
-
Price and volume
Market cap
$62m
Beta
0.04
52-week high
$14.76
52-week low
$8.45
Average daily volume
7.1k
Financial strength
Current ratio
0.08
Interest coverage (TTM)
-67.82%
Profitability
Gross margin (TTM)
100.00%
Net profit margin (TTM)
34,359.17%
Operating margin (TTM)
-4,054.68%
Management effectiveness
Return on assets (TTM)
-1.64%
Return on equity (TTM)
22.45%
Valuation
Price to earnings (TTM)
5.849
Price to revenue (TTM)
2,009.86
Price to book
1.17
Price to tangible book (TTM)
1.17
Price to free cash flow (TTM)
93.937
Free cash flow yield (TTM)
1.06%
Free cash flow per share (TTM)
0.113
Growth
Revenue change (TTM)
-77.71%
Earnings per share change (TTM)
1,567.33%
3-year revenue growth (CAGR)
-51.34%
10-year revenue growth (CAGR)
-30.72%
3-year earnings per share growth (CAGR)
14.52%
10-year earnings per share growth (CAGR)
-2.66%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs